Search

To investigate a possible relationship between the severity of pathological and radiological lesions in diffusion-weighted MRI (DWI) we compared DWI findings from 6 sequential brain MRI scans with pathological features of numerous tissue blocks of different cortical and subcortical regions in a case of autopsy-proven sporadic CJD. Whereas DWI and pathological examination revealed multifocal, cortical and deep hyperintensities at corresponding localizations, no correlation between the degree of severity of radiologically visible and pathological damage was found. The characteristic focal involvement and extension of lesions of the cortex and the basal ganglia bilaterally shown by DWI may be an argument for the spreading of the disease per contiguitatem.

Resume Les mouvements anormaux sont actuellement subdivises en syndromes akinetiques et en syndromes hyperkinetiques. Parmi ces derniers, la dystonie, l'athetose, la choree et le ballisme ont, comme point commun, le dysfonctionnement des circuits des noyaux gris centraux qui provoque leur survenue. La derniere decennie a ete marquee par l'avenement d'une meilleure definition de ces circuits et le developpement de la biologie moleculaire qui, tous deux, ont amene a une meilleure comprehension de ces mouvements involontaires tant d'un point de vue physiopathologique qu'etiologique. Ainsi, l'approche courante des mouvements anormaux fait appel, en plus de leur reconnaissance semiologique, a une connaissance de l'important diagnostic differentiel qui les sous-tend afin de diriger les examens paracliniques et d'engager un traitement adequat. La panoplie therapeutique s'etend avec l'apparition de traitements potentiellement neuroprotecteurs, neuroreconstructeurs et des traitements symptomatiques medicamenteux, par injection de toxine botulique et neurochirurgicaux telle la stimulation cerebrale profonde.

OBJECTIVE: Benzodiazepines and "Z drug" GABA receptor modulators (BDZ) are among the most frequently used drugs in hospitals. Adverse drug events (ADE) associated with BDZ can be the result of preventable medication errors (ME) related to dosing drug interactions and comorbidities. The present study evaluated inpatient use of BDZ and related ME and ADE. METHODS: We conducted an observational study within a pharmacoepidemiological database derived from the clinical information system of a tertiary care hospital. We developed algorithms that identified dosing errors and interacting comedication for all administered BDZ. Associated ADE and risk factors were validated in medical records. RESULTS: Among 53081 patients contributing 495813 patient days BDZ were administered to 25626 patients (48.3) on 115150 patient days (23.2). We identified 3372 patient days (2.9) with comedication that inhibits BDZ metabolism and 1197 (1.0) with lorazepam administration in severe renal impairment. After validation we classified 134 56 12 and 3 cases involving lorazepam zolpidem midazolam and triazolam respectively as clinically relevant ME. Among those there were 23 cases with associated adverse drug events including severe CNS depression falls with subsequent injuries and severe dyspnea. Causality for BDZ was formally assessed as 'possible' or 'probable' in 20 of those cases. Four cases with ME and associated severe ADE required administration of the BDZ antagonist flumazenil. CONCLUSIONS: BDZ use was remarkably high in the studied setting frequently involved potential ME related to dosing co medication and comorbidities and rarely cases with associated ADE. We propose the implementation of automated ME screening and validation for the prevention of BDZ related ADE.

Patients on levodopa therapy frequently require additional antipsychotic pharmacotherapy. However, consideration must be given to antagonistic interactions on dopamine receptors between levodopa and antipsychotics, and efficacy and safety of such combinations. We therefore aimed to explore the practice and rationale of coprescription between levodopa and antipsychotics in psychiatric patients. A descriptive retrospective study based on cross-sectional prescription data repeatedly collected from psychiatric inpatients through the international Drug Safety in Psychiatry (AMSP) program between 1994 and 2008 was undertaken. Within a population of 84 596 psychiatric patients the prevalence of levodopa therapy was 1.0% (n=886). Among those patients on levodopa therapy 59.6% (n=528) also received antipsychotics. Quetiapine coprescription increased after its first marketing in 2000 to 45.9% in 2008. Coprescription of clozapine and olanzapine decreased from up to 25 and 22%, respectively, before to less than 10% after the introduction of quetiapine. Coprescribing of other antipsychotics remained approximately stable with average prevalences between 6 and less than 1%. Quetiapine has now replaced clozapine as the most frequently coprescribed neuroleptic in psychiatric patients with levodopa therapy. This is in accordance with recent data indicating a low potential for clinically relevant interactions with levodopa and efficacy against psychosis in levodopa-treated patients. The combined use of antipsychotics other than quetiapine and clozapine with levodopa is less common and generally not supported by appropriate evidence.

Background: Mutism and dense retrograde amnesia are found both in organic and dissociative contexts. Moreover, dissociative symptoms may be modulated by right prefrontal activity. A single case, M.R., developed left hemiparesis, mutism and retrograde amnesia after a high-voltage electric shock without evidence of lasting brain lesions. M.R. suddenly recovered from his mutism following a mild brain trauma 2 years later. Methods: M.R.’s neuropsychological pattern and anatomoclinical correlations were studied through (i) language and memory assessment to characterize his deficits, (ii) functional neuroimaging during a standard language paradigm, and (iii) assessment of frontal and left insular connectivity through diffusion tractography imaging and transcranial magnetic stimulation. A control evaluation was repeated after recovery. Findings: M.R. recovered from the left hemiparesis within 90 days of the accident, which indicated a transient right brain impairment. One year later, neurobehavioral, language and memory evaluations strongly suggested a dissociative component in the mutism and retrograde amnesia. Investigations (including MRI, fMRI, diffusion tensor imaging, EEG and r-TMS) were normal. Twenty-seven months after the electrical injury, M.R. had a very mild head injury which was followed by a rapid recovery of speech. However, the retrograde amnesia persisted. Discussion: This case indicates an interaction of both organic and dissociative mechanisms in order to explain the patient’s symptoms. The study also illustrates dissociation in the time course of the two different dissociative symptoms in the same patient.

Hintergrund: Wir berichteten kurzlich uber die Validierung eines einstufigen monoklonalen chromatographischen Immunoassays (Schnelltest) zum Nachweis von H. pylori Antigen im Stuhl verglichen mit dem etablierten monoklonalen EIA auf (Eur J Clin Microbiol Infect Dis 2007; 26:475–80). Die Evaluation gegen Biopsie-basierte Methoden zeigte eine masige Sensitivitat bei guter Spezifitat. Unterschiedliche Ergebnisse zwischen zwei Untersuchern traten in 11,2% der Proben. Wir berichten uber eine verbesserte Version dieses Schnelltests. Methodik: Verblindete Stuhlproben symptomatischer Kinder (0,3–18 Jahre) wurden mit dem Schnelltest und dem monoklonalen EIA getestet. Der Schnelltest wurde durch 2 unabhangige Untersucher abgelesen. Als „Goldstandard“ fur eine H. pylori Infektion galt vor Therapie (n=185) eine positive Kultur und/oder mindestens zwei andere positive Tests. Nach Therapie (n=58) wurden die Ergebnisse beider Stuhltests mit dem 13C-Harnstoff-Atemtest verglichen. Bei 14 von 58 Patienten war die Therapie fehlgeschlagen. Ergebnisse: Von 243 Schnelltests war nur 1 Test (0,4%) aus technischen Grunden ungultig (bei Wiederholung negativ). Unklare Ergebnisse (sehr schwache Bande) wurden 16 mal durch Untersucher 1 und 27 mal durch Untersucher 2 abgelesen. Bei Wertung dieser sehr schwachen Bande als positives Ergebnis war eine Ubereinstimmung bei 76 positiven und 160 negativen Resultaten gegeben. Unterschiedliche Ergebnisse wurden 7 mal (2,9%) berichtet. Die Sensitivitat bei Untersucher 1 & 2 betrug 90,8% bzw. 85,5%, die Spezifitat entsprechend 91,0% & 93,4%, jeweils ohne Unterschied vor und nach Therapie. Der monoklonale EIA zeigte ausgezeichnete Ergebnisse fur Sensitivitat und Spezifitat (94,7 & 97,6%). Schlussfolgerung: Der verbesserte chromatographische Immunoassay scheint eine exzellente Alternative fur Situationen, in denen der monoklonale EIA oder der 13C-Harnstoff-Atemtest nicht verfugbar oder durchfuhrbar sind. Das Ergebnis des Schnelltests liegt innerhalb von 10 Minuten vor. Sehr schwache Banden sollten als positiv bewertet werden.

An ambulatory system for quantification of tremor and bradykinesia in patients with Parkinson's disease (PD) is presented. To record movements of the upper extremities, a sensing units which included miniature gyroscopes, has been fixed to each of the forearms. An algorithm to detect and quantify tremor and another algorithm to quantify bradykinesia have been proposed and validated. Two clinical studies have been performed. In the first study, 10 PD patients and 10 control subjects participated in a 45-min protocol of 17 typical daily activities. The algorithm for tremor detection showed an overall sensitivity of 99.5% and a specificity of 94.2% in comparison to a video reference. The estimated tremor amplitude showed a high correlation to the Unified Parkinson's Disease Rating Scale (UPDRS) tremor subscore (e.g., ${rm r} = 0.87$, ${rm p} < 0.001$ for the roll axis). There was a high and significant correlation between the estimated bradykinesia related parameters estimated for the whole period of measurement and respective UPDRS subscore (e.g., ${rm r} =-0.83$, ${rm p} < 0.001$ for the roll axis). In the second study, movements of upper extremities of 11 PD patients were recorded for periods of 35 hr. The patients were moving freely during the measurements. The effects of selection of window size used to calculate tremor and bradykinesia related parameters on the correlation between UPDRS and these parameters were studied. By selecting a window similar to the period of the first study, similar correlations were obtained. Moreover, one of the bradykinesia related parameters showed significant correlation (${rm r} = -0.74 $, ${rm p} < 0.01$) to UPDRS with window sizes as short as 5 min. Our study provides evidence that objective, accurate and simultaneous assessment of tremor and bradykinesia can be achieved in free moving PD patients during their daily activities.

A new ambulatory method of monitoring physical activities in Parkinson's disease (PD) patients is proposed based on a portable data-logger with three body-fixed inertial sensors. A group of ten PD patients treated with subthalamic nucleus deep brain stimulation (STN-DBS) and ten normal control subjects followed a protocol of typical daily activities and the whole period of the measurement was recorded by video. Walking periods were recognized using two sensors on shanks and lying periods were detected using a sensor on trunk. By calculating kinematics features of the trunk movements during the transitions between sitting and standing postures and using a statistical classifier, sit-to-stand (SiSt) and stand-to-sit (StSi) transitions were detected and separated from other body movements. Finally, a fuzzy classifier used this information to detect periods of sitting and standing. The proposed method showed a high sensitivity and specificity for the detection of basic body postures allocations: sitting, standing, lying, and walking periods, both in PD patients and healthy subjects. We found significant differences in parameters related to SiSt and StSi transitions between PD patients and controls and also between PD patients with and without STN-DBS turned on. We concluded that our method provides a simple, accurate, and effective means to objectively quantify physical activities in both normal and PD patients and may prove useful to assess the level of motor functions in the latter.

Background Long-duration response (LDR) to levodopa is supposed to decrease with Parkinson disease (PD) progression, but direct observation of this response in advanced PD has never been performed. Objective To study the LDR to levodopa in patients with advanced PD treated with subthalamic deep brain stimulation (DBS). Design and Setting We studied 30 consecutive patients with PD who underwent subthalamic DBS. One group had no antiparkinsonian treatment since surgery (no-levodopa group), whereas medical treatment had to be reinitiated in the other group (levodopa group). Main Outcome Measure Motor subscale score of the Unified Parkinson's Disease Rating Scale. Results Compared with preoperative assessment, evaluation 6 months postoperatively with DBS turned off for 3 hours found a worsening of the motor subscale score of the Unified Parkinson's Disease Rating Scale in the no-levodopa group. This worsening being absent in the levodopa group, it probably reflected the loss of the LDR to levodopa in the no-levodopa group. When DBS was turned on, postoperative motor subscale scores of the Unifid Parkinson's Disease Rating Scale in both groups were similar to preoperative scores while receiving medication, suggesting that subthalamic DBS compensated for the short-duration response and LDR to levodopa. Conclusions Our results suggest that the LDR to levodopa remains significant even in advanced PD, and that subthalamic DBS compensates for the short-duration response and LDR to levodopa.

The effects of subthalamic nucleus deep brain stimulation were studied in 52 consecutive patients (13 over age 70, 15 under age 60, 24 age 60 to 70). All groups had improvement of motor fluctuations and dyskinesia. Patients over age 70 had worsening of Unified Parkinson's Disease Rating Scale motor scores on medication, despite less medication reduction. Their activities of daily living and axial subscores worsened, particularly in those with preoperative gait difficulties.

The authors studied the long-term evolution of levodopa-induced dyskinesia (LID) after levodopa challenge in two groups of six STN-deep brain stimulation-treated Parkinson disease (PD) patients, one requiring medication after surgery and the other not. A dramatic (96%) reduction of LID severity was obtained in the six postoperatively untreated patients compared to a moderate improvement (47%) in the treated group (p < 0.03). These data support dopaminergic stimulation and striatal desensitization as major determinants of LID in PD.

Two groups of 10 Parkinson's disease (PD) patients and 10 age-matched normal subjects performing normal life activities were recorded using a portable recorder and 3D gyroscopes. PD patients had sub-thalamic stimulation implantation for 20/spl plusmn/3 months. The PD patients performed the test twice: with and without stimulation. Bradykinesia and tremor of hands in PD patients was quantified and strong correlation between this objective method and unified Parkinson's disease rating scale (UPDRS) clinical score was found.

Background Chronic diseases involving the putamen and globus pallidus induce parkinsonism and other movement disorders. Sensory and motor dysfunction from deep middle cerebral artery infarction is usually due to an involvement of the internal capsule. The clinical picture associated with isolated infarction of the lenticular nucleus is less well established. Objective To analyze clinical features, topographic correlations, and cause of purely lenticular ischemic infarction. Patients and Methods We reviewed 820 consecutive patients with deep hemispheral infarct included in the Lausanne Stroke Registry between 1986 and 1998 and selected those with isolated lenticular involvement on computed tomography or magnetic resonance imaging. Results Thirteen patients had pure lenticular infarction. All had faciobrachiocrural hemisyndrome, while none showed acute or delayed parkinsonism or abnormal movement. Nine patients had a lesion restricted to the putamen. Two of them had ataxic motor hemisyndrome and 7 had sensorimotor hemisyndrome (with ataxia in 4, left hemineglect in 1, and deep pain in the arm and leg in 1). Four patients had a lesion of putamen and globus pallidus externus.Three of them had motor hemisyndrome (with nonfluent aphasia in 2 and ataxia in 1) and 1 had ataxic sensorimotor hemisyndrome. All infarcts were in the territory of the medial perforating branches of the medial cerebral artery. Presumed cause of stroke was small-artery disease in 5, artery-to-artery embolism in 4, cardioembolism in 3 and undetermined in 1. Conclusions Acute lenticular infarction induces mainly hemiparesis but no movement disorder. Associated sensory deficits, aphasia, and hemineglect underline clinically the function of the lenticular nucleus in connection with the prefrontal, temporal, and parietal cortices.

Die Carbanionen von 1,1-Disulfon-athanen (1a, 1b) oder Halogen-disulfon-methanen (1e) reagieren mit α-Halogenathern unter Bildung von 1-Alkoxy-2,2-disulfon-propanen (3a, 3b) bzw. 1-Halogen-1,1-disulfon-2-alkoxy-athanen (3e). Aus Diathylsulfon-methan und Chlormethylather entsteht 1,3-Bismethoxy-2,2-bisathylsulfon-propan (6b). 1-Alkoxy-2,2-disulfon-propane (3a, 3d) sind auch zuganglich durch Oxidation der mittles Kondensation von Alkoxy-aceton (4) und Mercaptanen erhaltenen Mercaptale 5. 1-Alkoxymethyl-1.1-bissulfonyl Alkanes Via the carbanions of 1.1-bissulfonyl ethanes (1a, 1b) and bissulfonyl halomethanes (1e) with α-haloethers, 1-alkoxy-2.2-bissulfonyl propanes (3a, 3b) and 1-halo-1.1-bissulfonyl-2-alkoxyethanes (3e) are prepared. From diethylsulfonyl methane and chloromethyl ether results 1.3-bismethoxy-2.2-bisethylsulfonyl propane (6b). 1-Alkoxy-2.2-bissulfonyl propanes (3a, 3d) are also formed by oxidation of the thioacetals 5 which have been obtained by condensation of mercaptans with alkoxyacetone (4).

1,1-Dialkylsulfon-athane sowie Halogen-dialkylsulfon-methane lassen sich uber ihre Carbanionen mit N-Chlormethyl-aminen, -amiden oder -imiden aminomethylieren. Aminomethylation of Geminal Bisalkylsulfonyl Alkanes The carbanions of 1,1-bisalkylsulfonyl ethanes and bisalkylsulfonyl halomethanes with chloromethyl amines, amides or imides are aminomethylated.

An ambulatory gait analysis method using body-attached gyroscopes to estimate spatio-temporal parameters of gait has been proposed and validated against a reference system for normal and pathologic gait. Later, ten Parkinson's disease (PD) patients with subthalamic nucleus deep brain stimulation (STN-DBS) implantation participated in gait measurements using our device. They walked one to three times on a 20-m walkway. Patients did the test twice: once STN-DBS was ON and once 180 min after turning it OFF. A group of ten age-matched normal subjects were also measured as controls. For each gait cycle, spatio-temporal parameters such as stride length (SL), stride velocity (SV), stance (ST), double support (DS), and gait cycle time (GC) were calculated. We found that PD patients had significantly different gait parameters comparing to controls. They had 52% less SV, 60% less SL, and 40% longer GC. Also they had significantly longer ST and DS (11% and 59% more, respectively) than controls. STN-DBS significantly improved gait parameters. During the Stim ON period, PD patients had 31% faster SV, 26% longer SL, 6% shorter ST, and 26% shorter DS. GC, however, was not signiflicantly different. Some of the gait parameters had high correlation with Unified Parkinson's Disease Rating Scale (UPDRS) subscores including SL with a significant correlation (τ = -0.90) with UPDRS gait subscore. We concluded that our method provides a simple yet effective way of ambulatory gait analysis in PD patients with results confirming those obtained from much more complex and expensive methods used in gait labs.